XML 56 R38.htm IDEA: XBRL DOCUMENT v3.24.3
FINANCIAL RISK MANAGEMENT
12 Months Ended
Jun. 30, 2024
Notes and other explanatory information [abstract]  
FINANCIAL RISK MANAGEMENT

32. FINANCIAL RISK MANAGEMENT

 

This note explains the Company’s exposure to financial risks and how these risks could affect the Company’s future financial performance.

 

The Company’s risk management is predominantly controlled by the board. The board monitors the Company’s financial risk management policies and exposures and approves substantial financial transactions. It also reviews the effectiveness of internal controls relating to market risk, credit risk and liquidity risk.

 

(a) Market risk

 

(i) Foreign exchange risk

 

The Company undertakes certain transactions denominated in foreign currency and is exposed to foreign currency risk through foreign exchange rate fluctuations.

 

Foreign exchange rate risk arises from financial assets and financial liabilities denominated in a currency that is not the Company’s functional currency. Exposure to foreign currency risk may result in the fair value of future cash flows of a financial instrument fluctuating due to the movement in foreign exchange rates of currencies in which the Company holds financial instruments which are other than the Australian dollar (AUD) functional currency of the Company. This risk is measured using sensitivity analysis and cash flow forecasting. The cost of hedging at this time outweighs any benefits that may be obtained.

 

The consolidated financial statements are presented in Australian Dollar ($), which is Genetic Technologies Limited’s functional and presentational currency.

 

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (cont.)

 

32. FINANCIAL RISK MANAGEMENT (cont.)

 

Exposure

 

The Company’s exposure to foreign currency risk at the end of the reporting period, expressed in Australian dollar, was as follows:

 

   June 30, 2024   June 30, 2023 
   USD   CAD   EUR   GBP   NZD   USD   CAD   EUR    GBP 
   A$   A$   A$   A$   A$   A$   A$   A$    A$ 
Cash at Bank / on hand   492,038    38,571    129,130    124,588    39,600    1,296,082    10,766    100,369    41,858 
Trade and other receivables   82,717    20,388    41,303    36,324    6,142    611,193    11,252    17,690    26,376 
Trade and other payables   (559,850)   (4,557)   (262,179)   (50,810)   (3,553)   (455,167)   (3,795)   (151,327)   (31,441)

 

Sensitivity

 

As shown in the table above, the Company is primarily exposed to changes in USD/AUD exchange rates. The sensitivity of profit or loss to changes in the exchange rates arises mainly from USD denominated financial instruments.

 

The Company has conducted a sensitivity analysis of its exposure to foreign currency risk. Based on the financial instruments held as at June 30, 2024, had the Australian dollar weakened/strengthened by 3.65% (2023: 3.65%) against the USD with all other variables held constant, the Company’s post-tax loss for the year would have been A$544 lower/higher (2023: A$52,988 lower/higher).

 

USD: 3.65% (2023: 3.65%)

 

The Company is less sensitive to movements in the AUD/USD exchange rates in 2024 than 2023 because of the reduced amount of USD denominated cash and cash equivalents. The Company’s exposure to other foreign exchange movements is not material.

 

(b) Credit risk

 

Exposure to credit risk relating to financial assets arises from the potential non-performance by counterparties of contract obligations that could lead to a financial loss to the Company.

 

(i) Risk management

 

Credit risk is managed through the maintenance of procedures (such as the utilization of systems for the approval, granting and renewal of credit limits, regular monitoring of exposures against such limits and monitoring the financial stability of significant customers and counterparties), ensuring to the extent possible that customers and counterparties to transactions are of sound credit worthiness. Such monitoring is used in assessing receivables for impairment. Credit terms are normally 30 days from the invoice date.

 

Risk is also minimized through investing surplus funds in financial institutions that maintain a high credit rating.

 

(ii) Security

 

For some trade receivables the Company may obtain security in the form of guarantees, deeds of undertaking or letters of credit which can be called upon if the counterparty is in default under the terms of the agreement.

 

(iii) Impairment of financial assets

 

The Company has one type of financial asset subject to the expected credit loss model:

 

  trade receivables for sales of inventory

 

While cash and cash equivalents are also subject to the impairment requirements of IFRS 9, the identified impairment loss was immaterial.

 

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (cont.)

 

32. FINANCIAL RISK MANAGEMENT (cont.)

 

(b) Credit risk (Cont.)

 

(iii) Impairment of financial assets (Cont.)

 

Trade receivables

 

The Company applies the IFRS 9 simplified approach to measuring expected credit losses which uses a lifetime expected loss allowance for all trade receivables.

 

To measure the expected credit losses, trade receivables assets have been grouped based on shared credit risk characteristics and the days past due.

 

(c) Liquidity risk

 

Liquidity risk arises from the possibility that the Company might encounter difficulty in settling its debts or otherwise meeting its obligations related to financial liabilities. The Company manages this risk through the following mechanisms:

 

preparing forward looking cash flow analyses in relation to its operating, investing and financing activities;
obtaining funding from a variety of sources;
maintaining a reputable credit profile;
managing credit risk related to financial assets;
investing cash and cash equivalents and deposits at call with major financial institutions; and
comparing the maturity profile of financial liabilities with the realization profile of financial assets.

 

(i) Maturities of financial liabilities

 

The tables below analyze the Company’s financial liabilities into relevant maturity groupings based on their contractual maturities. The amounts disclosed in the table are the contractual undiscounted cash flows.

 

Contractual maturities of 

Less than

6 months

  

6 – 12

months

   Between 1 and 2 years   Between 2 and 5 years  

Over 5

years

   Total contrac- tual cash flows   Carrying amount (assets)/ liabilities 
financial liabilities  A$   A$   A$   A$   A$   A$   A$ 
At June 30, 2024                                   
Trade and other payables   1,797,753    232,770    -    -    -    2,030,523    2,030,523 
Borrowings   643,546    -    -    -    -    643,546    643,546 
Lease liabilities   147,761    63,113    22,068    1,853    -    234,795    231,643 
Total   2,589,060    295,883    22,068    1,853    -    2,908,864    2,905,712 

 

Contractual maturities of 

Less than

6 months

  

6 – 12

months

   Between 1 and 2 years   Between 2 and 5 years  

Over 5

years

   Total contrac- tual cash flows   Carrying amount (assets)/ liabilities 
financial liabilities  A$   A$   A$   A$   A$   A$   A$ 
At June 30, 2023                                   
Trade and other payables   1,617,333    -    -    -    -    1,617,333    1,617,333 
Lease liabilities   158,316    161,154    208,957    21,636    1,817    551,880    532,846 
Total   1,775,649    161,154    208,957    21,636    1,817    2,169,213    2,150,179 

 

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (cont.)

 

32. FINANCIAL RISK MANAGEMENT (cont.)

 

(d) Interest rate risk

 

The Company’s main interest rate risk arises in relation to its short-term deposits with various financial institutions. If rates were to decrease, the Company may generate less interest revenue from such deposits. However, given the relatively short duration of such deposits, the associate risk is relatively minimal.

 

The Company has a Short-Term Investment Policy which was developed to manage the Company’s surplus cash and cash equivalents. In this context, the Company adopts a prudent approach that is tailored to cash forecasts rather than seeking high returns that may compromise access to funds as and when they are required. Under the policy, the Company deposits its surplus cash in a range of deposits / securities over different time frames and with different institutions in order to diversify its portfolio and minimize risk.

 

On a monthly basis, Management provides the Board with a detailed list of all cash and cash equivalents, showing the periods over which the cash has been deposited, the name and credit rating of the institution holding the deposit and the interest rate at which the funds have been deposited.

 

At June 30, 2024, if interest rates had changed by +/- 50 basis points from the year-end rates, with all other variables held constant, the Company’s loss for the year would have been A$420.74 lower / higher (2023: A$31,083 lower / higher), as a result of higher / lower interest income from cash and cash equivalents and deposits in place.

 

The exposure to interest rate risks and the effective interest rates of financial assets and liabilities, both recognized and unrealized, for the Company is as follows:

  

       Floating rate   Fixed rate   Carrying amount   Weighted average effective rate   Average maturity Period
   Year   A$   A$   A$   %   Days
Financial assets                            
Cash at bank / on hand   2024    84,148    936,460    1,020,608    3.51   At call
    2023    1,516,646    6,334,551    7,851,197    4.46   At call
Bonds / deposits   2024    -    18,790    18,790    -   At call
    2023    -    17,440    17,440    -   At call
Totals   2024    1,516,646    6,351,991    7,868,637         
    2023    1,516,646    6,351,991    7,868,637         
Financial liabilities                            
Borrowings   2024    -    643,546    643,546    16%  287 days
    2023    -    -    -    -   -
Leases   2024    -    231,643    231,643    4.77%  -
    2023    -    532,846    532,846    4.77%  -
Totals   2024    -    875,189    875,189         
    2023    -    532,846    532,846         

 

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (cont.)